ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,015 | -10.5% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $46,950 | +11.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $42,285 | +7.9% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $39,195 | +18.8% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $33,000 | -26.7% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $45,000 | +15.4% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $39,000 | +11.4% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $35,000 | -88.4% | 1,500 | -87.9% | 0.00% | -83.3% |
Q2 2021 | $303,000 | +31.2% | 12,350 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $231,000 | +391.5% | 12,350 | +425.5% | 0.01% | +200.0% |
Q4 2020 | $47,000 | +74.1% | 2,350 | +46.9% | 0.00% | +100.0% |
Q3 2020 | $27,000 | -12.9% | 1,600 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $31,000 | +34.8% | 1,600 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $23,000 | +64.3% | 1,600 | +128.6% | 0.00% | +100.0% |
Q4 2019 | $14,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,000 | -12.5% | 700 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $16,000 | -38.5% | 700 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $26,000 | -99.8% | 700 | -99.7% | 0.00% | -97.7% |
Q3 2017 | $13,045,000 | -29.4% | 256,571 | -19.6% | 0.04% | -27.9% |
Q2 2017 | $18,489,000 | +23.9% | 318,941 | +25.0% | 0.06% | +32.6% |
Q1 2017 | $14,927,000 | +4.6% | 255,170 | -0.6% | 0.05% | 0.0% |
Q4 2016 | $14,272,000 | +1615.4% | 256,799 | +1352.5% | 0.05% | +1433.3% |
Q3 2016 | $832,000 | -14.5% | 17,680 | -21.4% | 0.00% | -25.0% |
Q2 2016 | $973,000 | +42.9% | 22,500 | +12.9% | 0.00% | +33.3% |
Q1 2016 | $681,000 | -57.8% | 19,922 | -2.0% | 0.00% | -62.5% |
Q4 2015 | $1,613,000 | +0.9% | 20,322 | -25.3% | 0.01% | 0.0% |
Q3 2015 | $1,598,000 | +24.3% | 27,220 | +36.1% | 0.01% | +33.3% |
Q2 2015 | $1,286,000 | +18.5% | 19,999 | +12.4% | 0.01% | +20.0% |
Q1 2015 | $1,085,000 | +301.9% | 17,799 | +182.5% | 0.01% | +400.0% |
Q3 2014 | $270,000 | -42.9% | 6,300 | -33.0% | 0.00% | -50.0% |
Q2 2014 | $473,000 | +155.7% | 9,400 | +123.8% | 0.00% | +100.0% |
Q1 2014 | $185,000 | -50.5% | 4,200 | -54.3% | 0.00% | -50.0% |
Q4 2013 | $374,000 | – | 9,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
Birchview Capital, LP | 35,000 | $654,000 | 0.39% |